Abstract:In order to further characterize the difference of gender on the clinical, pathological status, survival and its predictive factors of patients on population-based lung cancer, and to determine time trends of gender differences, we analyzed the data which had been entered into Shanghai Cancer Registry System and executed by CDC. Data on demographics, stage at diagnosis, history and survival were obtained for all patients with primary bronchogenic carcinoma registered in Shanghai cancer registry system from 2002 to 2004. The time trends of the male and female incidence in the urban population from 1972 to 2004 were assessed using APC (annual percent change) analysis. Relative survival rates based on life-table analysis methods were calculated to estimate the benefit of cancer survival by compensating for the expected difference in baseline survival rates between male and female populations. Cox multi-variance analyses were used to evaluate prognostic factors; those factors were gender, age, residential area, pathological type, stage, and hospital grade. 23196 new cases of lung cancer were diagnosed during 2002 – 2004, the female crude incidence rate was 33.73/100000, and age-adjusted rate was 30.90/100000. The male crude incidence rate and the age-adjusted rate were higher than those of female. The APC of male and female crude incidence continued to rise during the past 33 years (1.723% vs 2.036%, p ≤0.01). The male age-adjusted incidence rate in tendency to reduce was seen in the urban area (APC was -0.605%, p ≤0.01), but no change in female (APC was -0.136, p >0.05). There were more stage IV cases and adenocarcinoma in women than those of men (47.5% vs. 40.0%, 86.1% vs. 47.8%, respectively, p ≤0.05).The overall 3-year survival rates and MST were significantly higher in women than men (17.05% vs. 14.01% 0.83 year vs. 0.77 year, p ≤ 0.01). Stage-specific survival rates of women were also statistically higher than those of men for each stage (p ≤ 0.05). The 3-year survival rates and MST were also significantly higher in women adenocarcinoma than men (30.38%: 22.66%, 1.48 year: 0.98 year, p ≤0.01). Female gender was an independent positive prognostic factor (p ≤ 0.01) by a multivariate Cox analysis, other positive prognostic factors were younger, urban area, squamous cancer, early stage, high-grade hospital. Shanghai is one of the high-incidence area of lung cancer in the world. The present study confirms that women had statistically better outcomes than men in different stages of disease. The reasons behind these gender differences remain unclear. Exogenous or endogenous estrogens, gene, smoking, psychology, etc, may play roles to develop of the lung cancer in women.

ANALYSIS OF LUNG CANCER INCIDENCE AND MORTALITY IN TIANJIN

Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas?

[Incidence of Lung Cancer in Jiashan, Zhejiang Province: Trend Analysis from 1987 to 2016 and Projection from 2017 to 2019].

Urban-rural disparity in cancer mortality and changing trend in Tianjin, China, during 1999 and 2016

Disparities of sex on cancer incidence and mortality in Jiashan county, Zhejiang province,1990-2014

The Incidence and Mortality of Lung Cancer among Residents in Yangpu District of Shanghai from 2002 to 2010

[Incidence Trends and Pathological Characteristics of Lung Cancer in Urban Beijing During Period of 1998 - 2007].

Secular trends in incidence of lung cancer by histological type in Beijing, China, 2000 - 2016.

Trend analysis of the incidence of prostate cancer in Tianjin between 1981 and 2004

Trend Analysis of Lung Cancer Incidence and Mortality in Xiamen (2011-2020)

An Analysis of Lung Cancer Incidence and Mortality from 30 Cancer Registries in China, 1998～2002

All-cause mortality in Tianjin, China, 1999-2004

Incidence and mortality of lung cancer in 2018 and the temporal trends from 2010 to 2018 in Henan province, China: a population-based registry study

Relationships between lung cancer incidences and air pollutants

Lung cancer incidence and mortality in China: Updated statistics and an overview of temporal trends from 2000 to 2016

[Incidence, Time Trend, Survival, and Predictive Factors of Lung Cancer in Shanghai Populations].

Attributable Causes Of Lung Cancer Incidence And Mortality In China

Lung Cancer Incidence in Female Rises Significantly in Urban Sprawl of Shanghai after Introduction of LDCT Screening.

Cancer incidence in Beijing, 2014.

C8-02: Study of Incidences, Time Trends of Female Lung Cancer, Survivals and Its Predictive Factors on Shanghai Population

[Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019]